Unknown

Dataset Information

Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir.


ABSTRACT:

Objective

The objective of this study was to assess the impact of treatment with dexamethasone, remdesivir or both on neurological complications in acute coronavirus diease 2019 (COVID-19).

Methods

We used observational data from the International Severe Acute and emerging Respiratory Infection Consortium World Health Organization (WHO) Clinical Characterization Protocol, United Kingdom. Hospital inpatients aged ≥18 years with laboratory-confirmed severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection admitted between January 31, 2020, and June 29, 2021, were included. Treatment allocation was non-blinded and performed by reporting clinicians. A propensity scoring methodology was used to minimize confounding. Treatment with remdesivir, dexamethasone, or both

SUBMITTER: Grundmann A 

PROVIDER: S-EPMC9874556 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature